Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages

International Immunopharmacology

Volumn 21, Issue 1, 2014, Pages 186-192

  Jang, Se Eun ^a   Han, Myung Joo ^a   Kim, Se Young ^b   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

^b AmorePacific Corporation   (South Korea)

Author keywords

Colitis; Lactobacillus plantarum CLP 0611; Macrophage; Polarization; TNF

Indexed keywords

ANTIGEN; ARGINASE 1; CD206 ANTIGEN; CLP 0611; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; PEROXIDASE; TRANSCRIPTION FACTOR AP 1; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM ISOLATION; COLITIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIMCHI; LACTIC ACID BACTERIUM; LACTOBACILLUS PLANTARUM; M1 MACROPHAGE; M2 MACROPHAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; WEIGHT REDUCTION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CHEMICALLY INDUCED; COLON; GENETICS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PATHOLOGY; SIGNAL TRANSDUCTION;

ADMINISTRATION, ORAL; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; COLITIS; COLON; CYTOKINES; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LACTOBACILLUS PLANTARUM; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED ICR; NF-KAPPA B; PEROXIDASE; PROBIOTICS; TRANSCRIPTION FACTOR AP-1; TRINITROBENZENESULFONIC ACID;

EID: 84901048534     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.04.021     Document Type: Article

References (30)

1. M.G. Neuman, and R.M. Nanau Inflammatory bowel disease: role of diet, microbiota, life style Transl Res 160 2012 29 44
2. F. Shanahan Gut flora in gastrointestinal disease Eur J Surg Suppl 587 2002 47 52
3. F. Rafii, J.G. Ruseler-Van Embden, and L.M. van Lieshout Changes in bacterial enzymes and PCR profiles of fecal bacteria from a patient with ulcerative colitis before and after antimicrobial treatments Dig Dis Sci 44 1999 637 642
4. I.A. Lee, E.A. Bae, Y.J. Hyun, and D.H. Kim Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice J Inflamm (Lond) 7 7 2010
5. P. Chandran, S. Satthaporn, A. Robins, and O. Eremin Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I) Surgeon 1 2003 63 75
6. P. Benno, C.E. Leijonmarck, U. Monsén, A. Uribe, and T. Midtvedt Functional alterations of the microflora in patients with ulcerative colitis Scand J Gastroenterol 28 1993 839 844
7. A. Aderem, and R.J. Ulevitch Toll-like receptors in the induction of the innate immune response Nature 406 2000 782 787
8. I.A. Lee, Y.J. Park, E.H. Joh, and D.H. Kim Soyasaponin Ab ameliorates colitis by inhibiting the binding of lipopolysaccharide (LPS) to Toll-like receptor (TLR)4 on macrophages J Agric Food Chem 59 2011 13165 13172
9. R.B. Sartor Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics and prebiotics Gastroenterology 126 2004 1620 1633
10. Y. Sanz, I. Nadal, and E. Sánchez Probiotics as drugs against human gastrointestinal infections Recent Pat Antiinfect Drug Discov 2 2007 148 156
11. M.P. Collins, and G.R. Gibson Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut Am J Clin Nutr 69 1999 s1052 s1057
12. J. Aggarwal, G. Swami, and M. Kumar Probiotics and their effects on metabolic diseases: an update J Clin Diagn Res 7 2013 173 177
13. J. Romeo, E. Nova, J. Wärnberg, S. Gómez-Martínez, L.E. Díaz Ligia, and A. Marcos Immunomodulatory effect of fibres, probiotics and synbiotics in different life-stages Nutr Hosp 25 2010 341 349
14. L. Peran, S. Sierra, M. Comalada, F. Lara-Villoslada, E. Bailon, and A. Nieto et al. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis Br J Nutr 97 2007 96 103
15. C. Daniel, S. Poiret, D. Goudercourt, V. Dennin, G. Leyer, and B. Pot Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model Appl Environ Microbiol 72 2006 5799 5805
16. Y.W. Chung, J.H. Choi, T.Y. Oh, C.S. Eun, and D.S. Han Lactobacillus casei prevents the development of dextran sulfate sodium-induced colitis in Toll-like receptor 4 mutant mice Clin Exp Immunol 151 2007 182 189
17. L. Peran, D. Camuesco, M. Comalada, E. Bailon, A. Henriksson, and J. Xaus et al. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis J Appl Microbiol 103 2007 836 844
18. I.A. Lee, E.A. Bae, J.H. Lee, H. Lee, Y.T. Ahn, and C.S. Huh et al. Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice Inflamm Res 59 2010 359 368
19. S.E. Jang, S.R. Hyam, M.J. Han, S.Y. Kim, B.G. Lee, and D.H. Kim Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages J Appl Microbiol 115 2013 888 896
20. E.H. Joh, I.A. Lee, I.H. Jung, and D.H. Kim Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation - the key step of inflammation Biochem Pharmacol 82 2011 278 286
21. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
22. K.A. Kim, W. Gu, I.A. Lee, E.H. Joh, and D.H. Kim High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway PLoS One 7 2012 e47713
23. L.N. Johnson, and M. Koval Cross-talk between pulmonary injury, oxidant stress, and gap junctional communication Antioxid Redox Signal 11 2009 355 367
24. T. Collins, M.A. Read, A.S. Neish, M.Z. Whitley, D. Thanos, and T. Maniatis Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine inducible enhancers FASEB J 9 1995 899 909
25. H. David, F. Masayuki, G.H. Yasmin, P.S. John, G. Tyralee, and M. Junsuke et al. Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury Lab Invest 90 2010 1295 1305
26. K. Kawaguchi, T. Matsumoto, and Y. Kumazawa Effects of antioxidant polyphenols on TNF-alpha-related diseases Curr Top Med Chem 11 2011 1767 1779
27. J.H. Lee, B. Lee, H.S. Lee, E.A. Bae, H. Lee, and Y.T. Ahn et al. Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis Int J Colorectal Dis 24 2009 231 237
28. J. Wei, and J. Feng Signaling pathways associated with inflammatory bowel disease Recent Pat Inflamm Allergy Drug Discov 4 2010 105 117
29. C.A. Ambarus, S. Krausz, M. van Eijk, J. Hamann, T.R. Radstake, and K.A. Reedquist et al. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages J Immunol Methods 375 2012 196 206
30. H. Kim, B.J. Jung, J.H. Jung, J.Y. Kim, S.K. Chung, and D.K. Chung Lactobacillus plantarum lipoteichoic acid alleviates TNF-α-induced inflammation in the HT-29 intestinal epithelial cell line Mol Cells 33 2012 479 486